Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In the SURMOUNT-1 trial, tirzepatide at 15 mg achieved a mean weight reduction of 20.9%, approximately 6 percentage points above semaglutide's best result in comparable populations
The guide on retatrutide dosing decisions helps evaluate this trade-off
Contraindications Do Not Use If You Have uncontrolled hypertension Have known cardiovascular disease Have a history of hypersensitivity to bremelanotide or any component of the formulation Are pregnant or planning to become pregnant Warnings and Precautions Transient increase in blood pressure and decrease in heart rate: Bremelanotide causes a transient increase in blood pressure (average of 1.9/1.7 mmHg systolic/diastolic, with larger increases in some patients) and a decrease in heart rate following administration
Maintaining adequate antioxidant capacity allows the body to adapt to physical stressors without tipping into prolonged fatigue or immune vulnerability
US$ 29.60
US$ 22.84
US$ 21.74
US$ 28.61
US$ 21.76
US$ 27.83
US$ 29.14
